The validity of 18F-GE180 as a TSPO imaging agent. (2019)
Attributed to:
MRC Centre for Neurodevelopmental Disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00259-019-4268-4
PubMed Identifier: 30656358
Publication URI: http://europepmc.org/abstract/MED/30656358
Type: Journal Article/Review
Volume: 46
Parent Publication: European journal of nuclear medicine and molecular imaging
Issue: 6
ISSN: 1619-7070